share_log

Recap: Vistagen Therapeutics Q3 Earnings

Recap: Vistagen Therapeutics Q3 Earnings

回顾:Vistagen Therapeutics第三季度收益
Benzinga ·  02/13 16:25

Vistagen Therapeutics (NASDAQ:VTGN) reported its Q3 earnings results on Tuesday, February 13, 2024 at 04:21 PM.

Vistagen Therapeutics(纳斯达克股票代码:VTGN)于2024年2月13日星期二下午4点21分公布了其第三季度财报。

Here's what investors need to know about the announcement.

以下是投资者需要了解的有关该公告的信息。

Earnings

收益

Vistagen Therapeutics beat estimated earnings by 26.67%, reporting an EPS of $-0.22 versus an estimate of $-0.3.

Vistagen Therapeutics的收益比预期高出26.67%,每股收益为-0.22美元,而估计为-0.3美元。

Revenue was up $231 thousand from the same period last year.

收入比去年同期增长了23.1万美元。

Past Earnings Performance

过去的收益表现

Last quarter the company beat on EPS by $0.02 which was followed by a 11.07% drop in the share price the next day.

上个季度,该公司的每股收益超过0.02美元,随后第二天股价下跌了11.07%。

To track all earnings releases for Vistagen Therapeutics visit their earnings calendar here.

要追踪Vistagen Therapeutics发布的所有财报,请在此处访问他们的财报日历。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成,并由编辑审阅。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发